Ewa Tykarska

Prof. Ewa Tykarska

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MKMalgorzata Kucinska
Malgorzata Kucinska
PSPaulina Skupin-Mrugalska
Paulina Skupin-Mrugalska
WSWojciech Szczolko
Wojciech Szczolko
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
MSMateusz Sciepura
Mateusz Sciepura
Marek MuriasMarek Murias
Marek Murias

Verified
Journal Article
Open access
PDF file
KWKamil Wdowiak
Kamil Wdowiak
NRNatalia Rosiak
Natalia Rosiak
ETEwa Tykarska
Ewa Tykarska
MZMarcin A Zarowski
Marcin A Zarowski
APAnita Płazińska
Anita Płazińska
Judyta Cielecka-PiontekJudyta Cielecka-Piontek
Judyta Cielecka-Piontek
This study aimed at obtaining hesperidin (Hed) and hesperetin (Het) systems with HP-β-CD by means of the solvent evaporation method. The produced systems were identified using infrared spectroscopy (FT-IR), X-ray powder diffraction (XRPD), and differential scanning calorimetry (DSC). Moreover, in silico docking and molecular dynamics studies were performed to assess the most preferable site of interactions between tested compounds and HP-β-CD. The changes of physicochemical properties (solubility, dissolution rate, and permeability) were determined chromatographically. The impact of modification on biological activity was tested in an antioxidant study as well as with regards to inhibition of enzymes important in pathogenesis of neurodegenerative diseases. The results indicated improvement in solubility over 1000 and 2000 times for Hed and Het, respectively. Permeability studies revealed that Hed has difficulties in crossing biological membranes, in contrast with Het, which can be considered to be well absorbed. The improved physicochemical properties influenced the biological activity in a positive manner by the increase in inhibitory activity on the DPPH radical and cholinoesterases. To conclude the use of HP-β-CD as a carrier in the formation of an amorphous inclusion complex seems to be a promising approach to improve the biological activity and bioavailability of Hed and Het.

1 October 2013 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Marcin WierzchowskiMarcin Wierzchowski
Marcin Wierzchowski
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
PSPaulina Skupin-Mrugalska
Paulina Skupin-Mrugalska
JKJustyna Kruk
Justyna Kruk
WJWeronika Jusiak
Weronika Jusiak
TGTomasz Gośliński
Tomasz Gośliński


1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Anna Stasiłowicz-KrzemieńAnna Stasiłowicz-Krzemień
Anna Stasiłowicz-Krzemień
ETEwa Tykarska
Ewa Tykarska
KLKornelia Lewandowska
Kornelia Lewandowska
MKMaciej Kozak
Maciej Kozak
Andrzej MiklaszewskiAndrzej Miklaszewski
Andrzej Miklaszewski
Judyta Cielecka-PiontekJudyta Cielecka-Piontek
Judyta Cielecka-Piontek
The nutraceutical system of curcumin-piperine in 2-hydroxypropyl-β-cyclodextrin was prepared by using the kneading technique. Interactions between the components of the system were defined by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR). Application of hydroxypropyl-β-cyclodextrin as a carrier-solubiliser improved solubility of the curcumin–piperine system, its permeability through biological membranes (gastrointestinal tract, blood–brain barrier) as well as the antioxidant, antimicrobial and enzyme inhibitory activities against acetylcholinesterase and butyrylcholinesterase. Graphical Abstract

Verified
Journal Article
Open access
PDF file
NRNatalia Rosiak
Natalia Rosiak
KWKamil Wdowiak
Kamil Wdowiak
ETEwa Tykarska
Ewa Tykarska
Judyta Cielecka-PiontekJudyta Cielecka-Piontek
Judyta Cielecka-Piontek
The present study reports amorphous solid dispersions (ASDs) of hesperidin (Hes) prepared by ball milling to improve its solubility and apparent solubility over the unmodified compound. The carriers were Soluplus® (Sol), alginate sodium (SA), and hydroxypropylmethylcellulose (HPMC). XRPD analysis confirmed full amorphization of all binary systems in 1:5 w/w ratio. One glass transition (Tg) observed in DSC thermograms of hesperidin:Soluplus® (Hes:Sol) and hesperidin:HPMC (Hes:HPMC) 1:5 w/w systems confirmed complete miscibility. The mathematical model (Gordon–Taylor equation) indicates that the obtained amorphous systems are characterized by weak interactions. The FT-IR results confirmed that hydrogen bonds are responsible for stabilizing the amorphous state of Hes. Stability studies indicate that the strength of these bonds is insufficient to maintain the amorphous state of Hes under stress conditions (25 °C and 60 °C 76.4% RH). HPLC analysis suggested that the absence of degradation products indicates safe hesperidin delivery systems. The solubility and apparent solubility were increased in all media (water, phosphate buffer pH 6.8 and HCl (0.1 N)) compared to the pure compound. Our study showed that all obtained ASDs are promising systems for Hes delivery, wherein Hes:Sol 1:5 w/w has the best solubility (about 300-fold in each media) and apparent solubility (about 70% in phosphate buffer pH 6.8 and 63% in HCl).